Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



What's Changed With MAKO Surgical?

In this video, Motley Fool health-care bureau chief Brenton Flynn takes a look at MAKO Surgical (Nasdaq: MAKO  ) and some recent information garnered from its 10-Q SEC filing, discussing how use of the company's surgical robots may be down this quarter as a result of the huge areas of population hit by Hurricane Sandy. The filing also discloses one area where MAKO's profit margins are expanding extremely quickly. For more details, follow along in the video below.

Digging deep into SEC filings isn't for everyone. If you'd rather get a simple, easy-to-understand take on the company, analyst and MAKO expert David Meier has written a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As a bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading. .

Read/Post Comments (1) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 21, 2012, at 8:06 AM, captainccs wrote:

    That hip procedures would have lower margins than knees is not news. That was clear when they discussed the hip implants well over a year ago, While the Restoris knee implants are in-house products, the hip implants are made by a third party. I wrote September 6, 2011:

    "Also, they have spent a lot of money gearing up for hip which should see triple the volume of knee (with a lower gross margin for the implants). Hip should boost the utilization rate from the current 6.4 per month. 2012 or 13 could see an important inflection point. They plan on launching hip towards the end of this year."

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2122509, ~/Articles/ArticleHandler.aspx, 10/24/2016 3:00:43 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,230.19 84.48 0.47%
S&P 500 2,150.70 9.54 0.45%
NASD 5,304.50 47.10 0.90%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****